US healthcare consultancy Quintiles is planning to acquire Boston-based decision-analytics and market research consulting firm Eidetics. Terms have not been disclosed.
Eidetics has provided full service research and analytics in drug development and commercialization for the past 20 years. Quintiles says the acquisition will strengthen its core consulting offerings in the areas of product development, commercialization and market access.
'The addition of Eidetics to our business will further strengthen our ability to provide our clients with distinctive, data-driven, strategic solutions to their toughest challenges throughout the product lifecycle,' explains Jay Norman, Quintiles Consulting President.
Jim Kirk, Partner at Eidetics, says the move will provide clients with enhanced clinical, patient and provider data, greater therapeutic depth and access to global resources.
The companies are online at www.quintiles.com and www.eidetics.com .
All articles 2006-23 written and edited by Mel Crowther and/or Nick Thomas, 2024- by Nick Thomas, unless otherwise stated.
Register (free) for Daily Research News
REGISTER FOR NEWS EMAILS
To receive (free) news headlines by email, please register online